Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atara Biotherapeutics (ATRA)
NASDAQ:ATRA
RESEARCH TOOLSreports
Holding ATRA?
Track your performance easily
See the Price Targets and Ratings of:
ATRA Analyst Ratings
Moderate Buy
2 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ATRA Stock 12 Month Forecast
Average Price Target
$13.33
▲(14.62% Upside)
| Highest Price Target$18.00 | Average Price Target$13.33 | Lowest Price Target$9.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
Reiterated
08/21/24
Mizuho Securities
Upgraded
08/16/24
Stifel Nicolaus
Reiterated
08/16/24
Canaccord Genuity
Reiterated
08/14/24
Goldman Sachs
$12.5→$11
Sell
-5.42%
Downside
Reiterated
07/17/24
Atara Biotherapeutics (ATRA) PT Lowered to $11 at Goldman SachsGoldman Sachs lowered its price target on Atara Biotherapeutics (NASDAQ: ATRA) to $11.00 (from $12.50) while maintaining a Sell rating.
Citi
$35→$10
Sell
-14.02%
Downside
Reiterated
11/22/23
Atara Biotherapeutics price target lowered to 40c from $1.40 at CitiAtara Biotherapeutics price target lowered to 40c from $1.40 at Citi
Evercore ISI
―
Hold
―
Downgraded
11/09/23
Evercore ISI downgrades Atara Biotherapeutics (ATRA) to In LineEvercore ISI analyst Johnathan Miller downgraded Atara Biotherapeutics (NASDAQ: ATRA) from Outperform to In Line.
Best Analysts Covering Atara Biotherapeutics
Which Analyst Should I Follow If I Want to Buy ATRA and Sell After:
1 Month
xxx
Success Rate
16/39 ratings generated profit
Average Return
+0.83%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 41.03% of your transactions generating a profit, with an average return of +0.83% per trade.
3 Months
xxx
Success Rate
17/39 ratings generated profit
Average Return
+4.54%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 43.59% of your transactions generating a profit, with an average return of +4.54% per trade.
1 Year
Success Rate
17/39 ratings generated profit
Average Return
+1.81%
reiterated a buy rating 3 months ago
Copying John Newman's trades and holding each position for 1 Year would result in 43.59% of your transactions generating a profit, with an average return of +1.81% per trade.
2 Years
xxx
Success Rate
5/43 ratings generated profit
Average Return
-56.38%
upgraded a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 11.63% of your transactions generating a profit, with an average return of -56.38% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ATRA Analyst Recommendation Trends
Rating
Mar 24
Apr 24
May 24
Jul 24
Aug 24
Strong Buy
2
2
2
1
3
Buy
1
1
1
1
1
Hold
3
3
6
5
6
Sell
0
0
1
2
2
Strong Sell
0
0
0
0
0
total
6
6
10
9
12
Each month's total comprises the sum of three months' worth of ratings.
ATRA Financial Forecast
ATRA Stock Forecast FAQ
What is ATRA’s average 12-month price target, according to analysts?
Based on analyst ratings, Atara Biotherapeutics’s 12-month average price target is $13.33.
What is ATRA’s upside potential, based on the analysts’ average price target?
Atara Biotherapeutics has 14.62% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ATRA a Buy, Sell or Hold?
Atara Biotherapeutics has a consensus rating of Moderate Buy which is based on 2 buy ratings, 2 hold ratings and 0 sell ratings.
What is Atara Biotherapeutics’s price target?
The average price target for Atara Biotherapeutics is $13.33. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $18.00 ,the lowest forecast is $9.00. The average price target represents 14.62% Increase from the current price of $11.63.
The highest analyst price target is $18.00 ,the lowest forecast is $9.00. The average price target represents 14.62% Increase from the current price of $11.63.
What do analysts say about Atara Biotherapeutics?
Atara Biotherapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of ATRA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.